Free Trial

Athira Pharma (ATHA) Short Interest Ratio & Short Volume

Athira Pharma logo
$0.64 -0.02 (-3.02%)
(As of 11/22/2024 ET)

Athira Pharma Short Interest Data

Athira Pharma (ATHA) has a short interest of 1.55 million shares, representing 4.38% of the float (the number of shares available for trading by the public). This marks a -0.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 14.16 million shares to cover all short positions.

Current Short Interest
1,550,000 shares
Previous Short Interest
1,560,000 shares
Change Vs. Previous Month
-0.64%
Dollar Volume Sold Short
$663,555.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
38,669,000 shares
Float Size
35,360,000 shares
Short Percent of Float
4.38%
Today's Trading Volume
191,578 shares
Average Trading Volume
14,159,144 shares
Today's Volume Vs. Average
1%
Short Selling Athira Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Athira Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATHA Short Interest Over Time

ATHA Days to Cover Over Time

ATHA Percentage of Float Shorted Over Time

Athira Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,550,000 shares $663,555.00 -0.6%4.4%0.3 $0.43
10/15/20241,560,000 shares $693,264.00 -0.6%4.4%1.9 $0.44
9/30/20241,570,000 shares $700,220.00 -4.9%4.4%2.1 $0.45
9/15/20241,650,000 shares $871,365.00 +66.2%4.7%2.3 $0.53
8/31/2024992,900 shares $3.07 million +0.2%2.8%1.7 $3.09
8/15/2024990,700 shares $2.96 million +0.2%2.8%7.4 $2.99
7/31/2024989,200 shares $3.16 million -8.4%2.8%7.6 $3.19
7/15/20241,080,000 shares $3.63 million -1.8%3.1%7.5 $3.36
6/30/20241,100,000 shares $2.92 million +8.9%3.1%7 $2.65
6/15/20241,010,000 shares $2.57 million +13.6%2.9%5.8 $2.54
5/31/2024889,500 shares $2.33 million -3.7%2.5%3.4 $2.62
5/15/2024923,300 shares $2.04 million -12.1%2.6%3 $2.21
4/30/20241,050,000 shares $2.07 million +1.0%3.0%3.1 $1.97
4/15/20241,040,000 shares $2.14 million +3.0%2.9%2.9 $2.06
3/31/20241,010,000 shares $2.77 million +3.1%2.9%2.5 $2.74
3/15/2024979,300 shares $2.57 million +25.0%2.8%2.2 $2.62
2/29/2024783,600 shares $3.02 million +20.5%2.2%2 $3.85
2/15/2024650,300 shares $2.38 million -9.4%1.8%1.9 $3.66
1/31/2024717,600 shares $2.27 million +39.6%2.1%2.2 $3.17
1/15/2024513,900 shares $1.54 million +25.4%1.5%1.6 $3.00
12/31/2023409,900 shares $996,057.00 -16.6%1.2%1.4 $2.43
12/15/2023491,600 shares $1.14 million -1.6%1.4%2.3 $2.31
11/30/2023499,600 shares $719,424.00 +3.0%1.4%2.7 $1.44
11/15/2023484,900 shares $770,991.00 -8.8%1.4%2.9 $1.59
10/31/2023531,500 shares $829,140.00 -6.2%1.5%3.6 $1.56
10/15/2023566,700 shares $1.01 million -23.6%1.6%4 $1.79
9/30/2023741,900 shares $1.50 million -7.6%2.1%5.1 $2.02
9/15/2023803,300 shares $1.62 million -2.5%2.3%5.3 $2.02
8/31/2023823,500 shares $1.84 million -17.3%2.3%3.4 $2.23
8/15/2023996,000 shares $2.66 million -16.3%2.8%3.8 $2.67
7/31/20231,190,000 shares $3.47 million -3.3%3.4%4.7 $2.92
7/15/20231,230,000 shares $3.78 million +7.0%3.5%4.9 $3.07
6/30/20231,150,000 shares $3.39 million -46.0%3.3%4.4 $2.95
6/15/20232,130,000 shares $6.48 million +3.9%6.1%7.7 $3.04
5/31/20232,050,000 shares $5.68 million No Change5.8%9 $2.77
5/15/20232,050,000 shares $5.88 million -5.5%5.8%9.6 $2.87
4/30/20232,170,000 shares $6.05 million -1.8%6.4%9.6 $2.79
4/15/20232,210,000 shares $5.68 million -9.4%6.5%8.3 $2.57
3/31/20232,440,000 shares $6.10 million +8.4%6.8%7.7 $2.50
3/15/20232,250,000 shares $6.05 million +9.8%N/A6.9 $2.69
A “Thank You Gift” From Pres. Trump - Genius (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

2/28/20232,050,000 shares $6.31 million +5.7%5.5%6.3 $3.08
2/15/20231,940,000 shares $6.44 million +4.9%5.2%5.9 $3.32
1/31/20231,850,000 shares $7.47 million +20.9%5.0%5.6 $4.04
1/15/20231,530,000 shares $5.89 million No Change4.1%4.8 $3.85
12/30/20221,530,000 shares $4.85 million -1.9%4.1%5.5 $3.17
12/15/20221,560,000 shares $4.96 million -4.3%N/A5.9 $3.18
11/30/20221,630,000 shares $5.07 million -3.0%N/A6.4 $3.11
11/15/20221,680,000 shares $5.29 million -6.2%N/A6.9 $3.15
10/31/20221,790,000 shares $5.92 million -2.2%N/A7 $3.31
10/15/20221,830,000 shares $5.87 million +0.6%5.1%5.9 $3.21
9/30/20221,820,000 shares $5.41 million -2.2%5.1%5.6 $2.97
9/15/20221,860,000 shares $6.64 million +3.3%5.2%3.3 $3.57
8/31/20221,800,000 shares $6.08 million -1.1%5.0%1.9 $3.38
8/15/20221,820,000 shares $7.10 million +2.8%5.1%1.9 $3.90
7/31/20221,770,000 shares $6.16 million -12.8%5.1%1.8 $3.48
7/15/20222,030,000 shares $6.98 million -27.2%5.9%2.2 $3.44
6/30/20222,790,000 shares $8.51 million -11.2%8.0%3.1 $3.05
6/15/20223,140,000 shares $25.81 million +6.8%9.0%4.1 $8.22
5/31/20222,940,000 shares $26.70 million +1.4%8.5%10.1 $9.08
5/15/20222,900,000 shares $24.01 million +7.4%8.3%10 $8.28
4/30/20222,700,000 shares $27.78 million +20.0%7.8%9.7 $10.29
4/15/20222,250,000 shares $26.46 million -1.3%6.5%7.8 $11.76
3/31/20222,280,000 shares $30.78 million -17.1%6.6%7.7 $13.50
3/15/20222,750,000 shares $26.57 million +13.2%8.0%10.3 $9.66
2/28/20222,430,000 shares $22.26 million +3.0%7.0%8.4 $9.16
2/15/20222,360,000 shares $24.00 million +18.6%6.8%7.5 $10.17
1/31/20221,990,000 shares $20.50 million -2.9%6.3%5.5 $10.30
1/15/20222,050,000 shares $22.65 million +0.5%6.0%5 $11.05
12/31/20212,040,000 shares $26.58 million +15.3%6.0%4.6 $13.03
12/15/20211,770,000 shares $22.97 million -9.2%5.2%4.1 $12.98
11/30/20211,950,000 shares $26.29 million +28.3%5.7%4.4 $13.48
11/15/20211,520,000 shares $23.85 million +29.9%4.4%3.6 $15.69
10/29/20211,170,000 shares $15.29 million +9.4%3.4%2.9 $13.07
10/15/20211,070,000 shares $10.23 million -6.1%3.2%2.9 $9.56
9/30/20211,140,000 shares $10.69 million -15.6%3.4%2.8 $9.38
9/15/20211,350,000 shares $13.62 million +20.5%4.0%2.4 $10.09
8/31/20211,120,000 shares $11.86 million -9.7%3.3%0.9 $10.59
8/13/20211,240,000 shares $12.19 million -6.1%3.6%1 $9.83
7/30/20211,320,000 shares $12.69 million No Change4.0%1.1 $9.61
7/15/20211,320,000 shares $13.09 million +9.1%4.0%1.1 $9.92
6/30/20211,210,000 shares $12.39 million -28.4%3.6%1.1 $10.24
6/15/20211,690,000 shares $31.65 million +21.6%5.1%1.7 $18.73
5/28/20211,390,000 shares $27.72 million +53.8%4.2%4.6 $19.94
5/14/2021904,000 shares $16.34 million +7.1%2.7%3.3 $18.08
4/30/2021843,800 shares $16.22 million -27.9%2.5%2.8 $19.22
4/15/20211,170,000 shares $20.46 million +25.6%3.5%3.1 $17.49
3/31/2021931,400 shares $15.74 million +16.3%2.8%2.3 $16.90
3/15/2021800,900 shares $17.27 million +26.4%2.5%1.8 $21.56
2/26/2021633,800 shares $13.24 million -4.4%2.0%1.5 $20.89
2/12/2021663,100 shares $14.87 million -17.9%2.0%1.7 $22.42
A “Thank You Gift” From Pres. Trump - Genius (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

1/29/2021807,900 shares $17.14 million -13.8%2.5%2.2 $21.21
1/15/2021937,200 shares $25.11 million No Change3.0%2.7 $26.79

ATHA Short Interest - Frequently Asked Questions

What is Athira Pharma's current short interest?

Short interest is the volume of Athira Pharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,550,000 shares of ATHA short. 4.38% of Athira Pharma's shares are currently sold short. Learn More on Athira Pharma's current short interest.

What is a good short interest percentage for Athira Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.38% of Athira Pharma's floating shares are currently sold short.

Is Athira Pharma's short interest increasing or decreasing?

Athira Pharma saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 1,550,000 shares, a decline of 0.6% from the previous total of 1,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Athira Pharma's float size?

Athira Pharma currently has issued a total of 38,669,000 shares. Some of Athira Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Athira Pharma currently has a public float of 35,360,000 shares.

How does Athira Pharma's short interest compare to its competitors?

4.38% of Athira Pharma's shares are currently sold short. Here is how the short interest of companies compare to Athira Pharma: Passage Bio, Inc. (3.21%), Agenus Inc. (13.16%), Aligos Therapeutics, Inc. (4.78%), Tiziana Life Sciences Ltd (0.37%), Coya Therapeutics, Inc. (1.40%), Immunic, Inc. (5.00%), Avalo Therapeutics, Inc. (0.10%), Adagene Inc. (0.03%), Milestone Pharmaceuticals Inc. (0.85%), Anixa Biosciences, Inc. (1.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Athira Pharma stock?

Short selling ATHA is an investing strategy that aims to generate trading profit from Athira Pharma as its price is falling. ATHA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Athira Pharma?

A short squeeze for Athira Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHA, which in turn drives the price of the stock up even further.

How often is Athira Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHA, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ATHA) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners